This study is currently not recruiting participants.
Phase II Randomized Double Blind Placebo Controlled Trial of Combination of Pimasertib with SAR245409 or of Pimasertib with SAR245409 Placebo in Subjects with Previously Treated Unresectable Low Grade Ovarian Cancer
Not Recruiting
18 years - 100 years
Female
Phase
N/A
Brief description of study.
The purpose of this study is to learn how cancer reacts to pimasertib on its own, or in combination with SAR245409.
Detailed description of study
The purpose of this study is to learn how cancer reacts to pimasertib on its own, or in combination with SAR245409.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Ovarian Cancer
Age:
18 years - 100 years
Gender: Female
Updated on
15 Jan 2014.
Study ID: 1310513494
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
